These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Postprandial hypotension.syncope in Shy-Drager syndrome and its treatment with oral L-DOPS]. Hasegawa Y, Koike Y, Matsuoka Y, Takahashi A. Nihon Naika Gakkai Zasshi; 1989 Jul; 78(7):939-43. PubMed ID: 2507719 [No Abstract] [Full Text] [Related]
5. Xamoterol in the treatment of orthostatic hypotension associated with multiple system atrophy (Shy-Drager syndrome). West JN, Stallard TJ, Dimmitt SB, Smith SA, Williams A, Littler WA. Q J Med; 1990 Feb; 74(274):209-13. PubMed ID: 1971724 [Abstract] [Full Text] [Related]
6. Clinical effects of L-threo-3,4-dihydroxyphenylserine in cases of parkinsonism and pure akinesia. Narabayashi H, Kondo T, Yokochi F, Nagatsu T. Adv Neurol; 1987 Feb; 45():593-602. PubMed ID: 3103397 [No Abstract] [Full Text] [Related]
7. Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome. Schirger A, Sheps SG, Thomas JE, Fealey RD. Mayo Clin Proc; 1981 Jul; 56(7):429-33. PubMed ID: 6166817 [Abstract] [Full Text] [Related]
8. [Hyperthermia in a Shy-Drager syndrome patient--pathophysiological effects of body temperature and L-DOPS on orthostatic hypotension]. Yamamoto K, Morita S, Ikeda S, Yanagisawa N. Rinsho Shinkeigaku; 1993 Jan; 33(1):68-73. PubMed ID: 8334778 [Abstract] [Full Text] [Related]
9. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Mathias CJ, Senard JM, Braune S, Watson L, Aragishi A, Keeling JE, Taylor MD. Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796 [Abstract] [Full Text] [Related]
10. Indomethacin and propranolol combined treatment for Shy-Drager syndrome. Galassi G. J Neurol Neurosurg Psychiatry; 1982 May; 45(5):472-3. PubMed ID: 7086460 [No Abstract] [Full Text] [Related]
11. Effect of prenalterol on orthostatic hypotension in the Shy-Drager syndrome. Goovaerts J, Verfaillie C, Fagard R, Knockaert D. Br Med J (Clin Res Ed); 1984 Mar 17; 288(6420):817-8. PubMed ID: 6142747 [Abstract] [Full Text] [Related]
12. Monoamine oxidase inhibitors and Sinemet in Shy-Drager syndrome. Rae-Grant A, Young GB, Spence JD. Neurology; 1985 Jul 17; 35(7):1085-6. PubMed ID: 4010957 [No Abstract] [Full Text] [Related]
13. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome. Kachi T, Iwase S, Mano T, Saito M, Kunimoto M, Sobue I. Neurology; 1988 Jul 17; 38(7):1091-4. PubMed ID: 3133573 [Abstract] [Full Text] [Related]
14. [A case with acute pandysautonomia with aseptic meningitis--Pathophysiological and therapeutic study]. Ushiyama M, Ikeda S, Yazawa M, Yanagisawa N, Takatsu M. Rinsho Shinkeigaku; 1987 Aug 17; 27(8):1035-42. PubMed ID: 3121228 [No Abstract] [Full Text] [Related]